0001209191-22-047651.txt : 20220825 0001209191-22-047651.hdr.sgml : 20220825 20220825193617 ACCESSION NUMBER: 0001209191-22-047651 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220823 FILED AS OF DATE: 20220825 DATE AS OF CHANGE: 20220825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sloan Leslie CENTRAL INDEX KEY: 0001719455 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 221199226 MAIL ADDRESS: STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC. STREET 2: 901 S.MOPAC EXPWY,BARTONOAKSPLAZONE,#250 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-23 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001719455 Sloan Leslie 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 0 1 0 0 Chief Operating Officer Employee Stock Option (right to buy) 0.68 2022-08-23 4 A 0 130000 0.00 A 2032-08-22 Common Stock 130000 130000 D The stock option vests and becomes exercisable in 48 equal monthly installments beginning on September 23, 2022 until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors, the stock option will vest as to 80% of the award by January 1, 2023, and 1/48 of the stock option will vest and become exercisable monthly thereafter until such time as the option is 100% vested. /s/ James Kastenmayer, by power of attorney 2022-08-25